Package 42291-971-60

Brand: zafirlukast

Generic: zafirlukast
NDC Package

Package Facts

Identity

Package NDC 42291-971-60
Digits Only 4229197160
Product NDC 42291-971
Product ID 42291-971_3b3c7fd6-2d93-6df8-e063-6294a90a841f
Description

60 TABLET, COATED in 1 BOTTLE (42291-971-60)

Marketing

Marketing Status
Marketed Since 2023-04-05
Brand zafirlukast
Generic zafirlukast
Sample Package No

Linked Drug Pages (1)

Zafirlukast ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3b3c7fd6-2d93-6df8-e063-6294a90a841f", "openfda": {"nui": ["N0000175777", "N0000000083", "N0000185504"], "unii": ["XZ629S5L50"], "rxcui": ["199655", "313758"], "spl_set_id": ["f89a821d-396f-a3aa-e053-6294a90a4577"], "pharm_class_epc": ["Leukotriene Receptor Antagonist [EPC]"], "pharm_class_moa": ["Leukotriene Receptor Antagonists [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, COATED in 1 BOTTLE (42291-971-60)", "package_ndc": "42291-971-60", "marketing_start_date": "20230405"}], "brand_name": "Zafirlukast", "product_id": "42291-971_3b3c7fd6-2d93-6df8-e063-6294a90a841f", "dosage_form": "TABLET, COATED", "pharm_class": ["Cytochrome P450 2C9 Inhibitors [MoA]", "Leukotriene Receptor Antagonist [EPC]", "Leukotriene Receptor Antagonists [MoA]"], "product_ndc": "42291-971", "generic_name": "zafirlukast", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zafirlukast", "active_ingredients": [{"name": "ZAFIRLUKAST", "strength": "20 mg/1"}], "application_number": "NDA020547", "marketing_category": "NDA", "marketing_start_date": "20230405", "listing_expiration_date": "20261231"}